Drugs / CTO0303-A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06609525 | May → Dec 2024 | cycloplegia | Taejoon Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CTO0303-A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06609525 ↗ |
| Route | Other | “eye drop, 1 drop 3 times (every 5 minutes) a day” NCT06609525 ↗ |